| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/24/2005 | CN1657634A Process for preparing active lactoferritin |
| 08/24/2005 | CN1657626A Antifungal polypeptide and its preparation method |
| 08/24/2005 | CN1657603A Mutant microorganism and method for producing peptide using the same |
| 08/24/2005 | CN1657601A Hebei Amycolatopsis hebeiensis bacterial strain and preparation Norvancomycin fermented by the strain |
| 08/24/2005 | CN1216149C Cell strain of expression mutation type human tissue plasminogen activator imethod for construction and preparation method of expressing protein |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933368 Increasing antibody affinity by altering glycosylation of immunoglobulin variable region |
| 08/23/2005 | US6933365 Mutant tyrosine repressor proteins |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933136 Method for making recombinant proteins |
| 08/23/2005 | US6933135 monoclonal antibody having intracellular domain of leukocyte antigen related molecule and domain of CD45; for prophylaxis and diagnosis of syndrome X, arteriosclerosis, and cardiovascular disorders based on insulin resistance |
| 08/23/2005 | US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1 |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6933110 Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease |
| 08/23/2005 | US6932967 Human medical treatment by aerosol inhalation of immunoglobulin A |
| 08/23/2005 | CA2368734C Method for preparing monoclonal antibody |
| 08/23/2005 | CA2142300C Methods for detecting alzheimer's disease |
| 08/23/2005 | CA2108000C Enhanced gene expression in plants using an hsp70 intron sequence |
| 08/23/2005 | CA2094276C Antibodies against the urokinase receptor and their use |
| 08/18/2005 | WO2005075660A1 Improved composition for cell-free protein synthesis |
| 08/18/2005 | WO2005075644A2 Leader sequence and method for synthesizing polypepides in cell-free systems |
| 08/18/2005 | WO2005075639A1 Method of constructing glycoprotein by using extension codon |
| 08/18/2005 | WO2005075448A2 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained |
| 08/18/2005 | WO2005074647A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | WO2005074436A2 Self-assembling split-fluorescent protein systems |
| 08/18/2005 | WO2005058952A3 Ztnf13, a tumor necrosis factor |
| 08/18/2005 | WO2005047487A8 Motoneuronotrophic factor gene sequences |
| 08/18/2005 | WO2005017174A3 Process for the purification of recombinant polypeptides |
| 08/18/2005 | WO2003072601A8 Method for producing hypoallergenic major birch pollen allergens rbet v 1 |
| 08/18/2005 | WO2003004608A3 Drug metabolizing enzymes |
| 08/18/2005 | WO2001058923A9 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 08/18/2005 | US20050182242 Microarray comprising double tagged fusion protein for monitoring and classification of polypeptide interactions in preferential species; high-throughput assay |
| 08/18/2005 | US20050181973 comprising alternating hydrophobic and hydrophilic amino acids that are complementary and structurally compatible; three-dimensional scaffolds, encapsulating cells, used for cell cultures, tissue engineering and tissue repair |
| 08/18/2005 | US20050181501 Anti-TECK antibodies and methods of use therefor |
| 08/18/2005 | US20050181495 Large scale productions of virus antigen |
| 08/18/2005 | US20050181494 Novel lambda phage display system and the process |
| 08/18/2005 | US20050181482 Immunoglobulin/erythropoietin fusion for use in stimulating blood cell production |
| 08/18/2005 | US20050181480 Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells |
| 08/18/2005 | US20050181471 artificial polynucleotide for incorporating an unnatural amino acid into a protein and attaching one or more saccharide moieties to the unnatural amino acid; mimetics; expression vector; kits |
| 08/18/2005 | US20050181462 Mutant androgen receptor, cancer cells expressing the same, a method of producing them and use thereof |
| 08/18/2005 | US20050181461 Assays for sensory modulators using a sensory cell specific G-protein alpha subunit |
| 08/18/2005 | US20050181458 Bioassay for measuring the proliferation of T-cells in Human papiloma virus |
| 08/18/2005 | US20050181452 Bioassay for functional characterization of G protein coupled and de-orphanization of receptors; high throughput screening; pharmacological profiling; drug screening and design |
| 08/18/2005 | US20050181448 Biological products |
| 08/18/2005 | US20050181439 Streptococcus pneumoniae antigens and vaccines |
| 08/18/2005 | US20050181419 For detection of Mycobacterium tuberculosis infection |
| 08/18/2005 | US20050181418 Using nuclear protein (AM-1) as screening tool in diagnosing metastatic cancer |
| 08/18/2005 | US20050181413 Ovarian specific nucleic acid (OSNA) for use as diagnostic and prognostic tools in treatment and prevention of urogenital cancers; genetic vaccines |
| 08/18/2005 | US20050181402 Immunoglobulin which specifically binds serum and glucocorticoid dependent kinase for diagnosing infection, inflammatory, kidney and liver disorders |
| 08/18/2005 | US20050181395 Systems for tightly regulated gene expression |
| 08/18/2005 | US20050181366 Molecular switches and methods for making and using the same |
| 08/18/2005 | US20050180994 or drug targets; determining a candidate's effect on ubiquitin ligase activity of the poxviral p28 polypeptide; ubiquitylating a substrate by combining an E1 polypeptide, an E2 polypeptide, ubiquitin and a poxvirus P28 protein; variola virus (smallpox) treatment; side effect reduction of vaccination |
| 08/18/2005 | US20050180981 Human checkpoint kinase, hCDS1, compositions and methods |
| 08/18/2005 | DE102004032460B3 In vitro synthesis of expression products, particularly proteins, in a cell-free system, comprises using a repetitive batch method, with periodic removal of metabolites and supplementation |
| 08/18/2005 | CA2585231A1 Self-assembling split-fluorescent protein systems |
| 08/18/2005 | CA2554784A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | CA2553040A1 Modified human four helical bundle polypeptides and their uses |
| 08/17/2005 | EP1564293A1 Neural thread protein gene expression and detection of Alzheimer's disease |
| 08/17/2005 | EP1564285A1 Method of obtaining cell lines in a protein-free medium and cell lines thus obtained |
| 08/17/2005 | EP1563084A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 08/17/2005 | EP1563075A1 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 08/17/2005 | EP1563073A2 Protein production methods and modified cells for use therein |
| 08/17/2005 | EP1562968A1 Anti-il-6 antibodies, compositions, methods and uses |
| 08/17/2005 | EP1562967A2 Adipocyte complement related protein zacrp14 |
| 08/17/2005 | EP1562630A2 Injectible bioadhesive polymeric hydrogels as well as related methods of enzymatic preparation |
| 08/17/2005 | EP1562587A2 Novel compositions and methods for the treatment of immune related diseases |
| 08/17/2005 | EP1519979A4 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 08/17/2005 | EP1461445A4 Glycoprotein remodeling using endoglycanases |
| 08/17/2005 | EP1419392A4 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 08/17/2005 | EP1345495A4 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 08/17/2005 | EP1161250B1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 08/17/2005 | EP1066372B1 Novel recombinant baculovirus, construction method thereof and insect pesticidal composition containing the same |
| 08/17/2005 | EP1051500B1 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 08/17/2005 | EP0972201B1 Compounds for immunodiagnosis of prostate cancer and methods for their use |
| 08/17/2005 | EP0939804B1 NEUTROKINE alpha |
| 08/17/2005 | EP0837880B1 Enamel matrix related polypeptide |
| 08/17/2005 | EP0833917B1 Malarial pre-erythrocytic stage polypeptide molecules |
| 08/17/2005 | EP0832189B1 Process for controlling sialylation of proteins produced by mammalian cell culture |
| 08/17/2005 | EP0742826B1 Multivariant il-3 hematopoiesis fusion protein |
| 08/17/2005 | CN1656213A Secretion of proteins with multiple disulfide bonds in bacteria and uses thereof |
| 08/17/2005 | CN1656122A Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 08/17/2005 | CN1656114A Novel pancortin-pablo protein interactions and methods of use thereof |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/17/2005 | CN1655669A Nucleic acid constructs and methods for producing altered seed oil compositions |
| 08/17/2005 | CN1654657A Novel streptococcus antigens |
| 08/17/2005 | CN1654654A Heavy chain and light chain variable region gene of human B lymphocyte stimulation factor monoclonal antibody and its application |
| 08/17/2005 | CN1654653A Novel natural antibacterial peptide HKABF and its preparation and application |
| 08/17/2005 | CN1654652A Amphioxus dimethyl arginine hydrolase AmphiDDAH gene and its application |
| 08/17/2005 | CN1654651A Novel natural antibacterial peptide Hippocampusin and its preparation and application |
| 08/17/2005 | CN1654648A Recombinant human aFGF production method by gene engineering expression in silkworm body |
| 08/17/2005 | CN1654647A Method for producing recombinant human lactoferrin in silkworm body by gene engineering technology |
| 08/17/2005 | CN1654646A High efficiency production method for recombinant silkworm antibacterial peptide CM4 |
| 08/17/2005 | CN1654643A Auxiliary renaturation process for preparing recombinant reteplase |
| 08/17/2005 | CN1654478A Method for preparing polyethylene glycol-modified alpha-interferon 1b |
| 08/17/2005 | CN1654475A Preparation and use of conservative region of recombinant helicobacter pylori adhesin |
| 08/17/2005 | CN1654473A 重组幽门螺杆菌过氧化氢酶 Recombinant H. pylori catalase |
| 08/17/2005 | CN1654472A Recombinant helicobacter pylori outer-membrane protein 25 |
| 08/17/2005 | CN1654471A Recombinant helicobacter pylori blood group antigen adhesin |